Recording EEG Did Not Make the Recognition-Memory Paper an EEG Results Report

The naturalistic cannabis experiment recorded EEG, but the recognition-memory publication stated that EEG results would be reported elsewhere. Equipment described in a method does not establish a neural finding absent from the paper’s results.

Several measurements were collected together

Participants completed word-recognition and flanker tasks in a mobile laboratory equipped for EEG. The methods describe recording during the study and testing sequences. That establishes that brain electrical activity was collected, not what its analysis ultimately showed.

The publication separated its outcome reports

The authors specify that EEG and flanker-task results would appear elsewhere. The reported recognition outcomes therefore should not be described as direct demonstrations of a particular brain-wave mechanism merely because the equipment was present.

Mechanistic claims need the actual analysis

Behavioral differences can motivate a hypothesis about neural processing. They do not identify an EEG signature, localize a causal pathway or show that a neural change mediated the memory result without supporting analyses. A related publication might address those questions, but it must be read and evaluated on its own terms. This is especially important when several reports arise from one experimental program: collection of multiple measures is different from independent replication. The present paper supplies recognition-memory evidence, not permission to invent an unreported electrophysiological explanation.

Related analysis: the study’s main findings and limitations.

Research cited

Paulich and colleagues. Naturalistic investigation of cannabis strains varying in THC and CBD ratios and verbal recognition memory. Frontiers in Psychology (2026). DOI: 10.3389/fpsyg.2025.1685412.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Rheumatoid-Arthritis Cannabis-Spray Trial Measured Pain Relief Rather Than Joint Protection

A small rheumatoid-arthritis trial summarized in a nabiximols review found improvement in selected pain outcomes. Those symptom findings did not establish that the spray prevented joint damage or replaced disease-modifying treatment. The trial tested a standardized combination The placebo-controlled study involved 58 patients treated for five weeks with THC:CBD oromucosal…

Spread the love

Read Article: A Rheumatoid-Arthritis Cannabis-Spray Trial Measured Pain Relief Rather Than Joint Protection

Responder Findings in a Small Nabiximols Chemotherapy-Pain Pilot Remained Exploratory

A small crossover pilot of nabiximols for chemotherapy-induced neuropathic pain did not show a significant average treatment effect, although a responder analysis identified some patients with meaningful relief. That pattern supports a research lead rather than a validated way to select responders. The average comparison was not positive The review’s…

Spread the love

Read Article: Responder Findings in a Small Nabiximols Chemotherapy-Pain Pilot Remained Exploratory

A Nabiximols Spinal-Cord-Injury Trial Found Similar Pain Changes With Spray and Placebo

A trial of THC:CBD spray for spinal-cord-injury neuropathic pain reported nearly identical average pain changes with active treatment and placebo. Improvement from baseline alone did not demonstrate an added spray benefit. The comparison concerned a defined pain population The review summarizes a randomized study registered as NCT01606202. Its evidence table…

Spread the love

Read Article: A Nabiximols Spinal-Cord-Injury Trial Found Similar Pain Changes With Spray and Placebo

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us